As of 2025-01-23, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (24.08) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -1179.7%.
The range of the Relative Valuation is (18.43) - (25.61) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 23.4x | 20.6x |
| Forward P/E multiples | 16.8x - 24.7x | 23.4x |
| Fair Price | (18.43) - (25.61) | (24.08) |
| Upside | -926.5% - -1248.4% | -1179.7% |
| Date | P/E |